Status:
ACTIVE_NOT_RECRUITING
What Matters to Patients With Severe Hip or Knee Osteoarthritis?
Lead Sponsor:
Vejle Hospital
Collaborating Sponsors:
Odense University Hospital
Conditions:
Hip Osteoarthritis
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial aims to investigate if shared decision-making, and the use of an in-consultation patient decision aid (PtDA), increases the decisional quality and therefore treatment satisfaction ...
Detailed Description
Osteoarthritis (OA) is the most common joint disease and a major cause of disability worldwide. The condition typically affects the hip or knee, and as the condition progresses it frequently causes de...
Eligibility Criteria
Inclusion
- Severe primary osteoarthritis eligible for primary total hip arthroplasty (THA) / primary total knee arthroplasty (TKA) / primary partial knee arthroplasty (UKA)
- Able to understand and read Danish
- Informed consent
Exclusion
- Previous THA, TKA, or UKA on the contralateral side
- Cognitive impairment
- Non-OA-related reason for the visit
- No digital mailbox (E-boks)
Key Trial Info
Start Date :
October 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2026
Estimated Enrollment :
615 Patients enrolled
Trial Details
Trial ID
NCT05972525
Start Date
October 11 2023
End Date
July 11 2026
Last Update
January 6 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital, OUH
Odense, Denmark, 5000
2
Odense University Hospital, OUH
Svendborg, Denmark, 5700
3
Lillebaelt Hospital - Vejle
Vejle, Denmark, 7100